[CBAY] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
08-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 7.78%
YoY- -40.06%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -11,421 -26,282 -18,563 -8,234 -5,879 -5,865 -5,961 11.43%
Tax -816 1,425 1,453 -1,540 422 1,348 -63 53.18%
NP -11,421 -26,282 -18,563 -8,234 -5,879 -5,865 -5,961 11.43%
Tax Rate - - - - - - - -
Total Cost 11,421 26,282 18,563 8,234 5,879 5,865 5,961 11.43%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.17 -0.38 -0.31 -0.21 -0.25 -0.27 -0.44 -14.64%
EPS Diluted -0.17 -0.38 -0.31 -0.21 -0.25 -0.27 -0.44 -14.64%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.